Altrinsic Global Advisors’s Cabaletta Bio CABA Stock Holding History

Altrinsic Global Advisors’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-140,000	Closed	-$531K	–	53
2021 Q4	$531K	Buy	140,000 +20,000	+17%	+$213K	0.02%	72
2021 Q3	$1.46M	Sell	120,000 -10,000	-8%	-$92.2K	0.04%	69
2021 Q2	$1.12M	Buy	130,000 +10,000	+8%	+$98.3K	0.03%	71
2021 Q1	$1.33M	Buy	120,000 +20,000	+20%	+$244K	0.04%	70
2020 Q4	$1.25M	Hold	100,000	–	–	0.04%	72
2020 Q3	$1.08M	Hold	100,000	–	–	0.04%	68
2020 Q2	$1.11M	Buy	+100,000	New	+$766K	0.05%	70

Other funds holding CABA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Altrinsic Global Advisors's CABA Position: Q1 2022 in Review

Altrinsic Global Advisors sold out of Cabaletta Bio (CABA) in Q1 2022, closing a stake of 140,000 shares — an estimated $531K sold.

Altrinsic Global Advisors first reported a position in CABA in Q2 2020 and held it in 7 quarters. The position peaked at $1.46M in Q3 2021. 62 funds tracked by Wall St. Rank hold CABA as of Q1 2022.

Altrinsic Global Advisors reported no remaining Cabaletta Bio position as of Q1 2022 after selling out during the quarter.
Altrinsic Global Advisors sold 140,000 Cabaletta Bio shares in Q1 2022, an estimated $531K.
Altrinsic Global Advisors first reported a position in Cabaletta Bio in Q2 2020 and held it in 7 quarters.
Altrinsic Global Advisors's Cabaletta Bio position peaked at $1.46M in Q3 2021.
62 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2022.

Based on Altrinsic Global Advisors's 13F filing for Q1 2022, filed 16 May 2022.